|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
|
|---|---|---|
| Revenue | ||
| COST OF REVENUES | ||
| GROSS PROFIT | ||
| OPERATING EXPENSES | ||
| Selling expenses | ||
| General and administrative expenses | ||
| Research and development expenses | ||
| Total operating expenses | ||
| NET LOSS FROM OPERATIONS | ||
| OTHER (EXPENSE) INCOME | ||
| Other income | ||
| Other expense | ||
| Loss from investments | ||
| Issuance costs allocated to warrant liabilities | ||
| Loss on issuance of warrant liabilities | ||
| Change in fair value of warrant liabilities | ||
| Total other (expense) income, net | ||
| NET LOSS BEFORE TAXES | ||
| Income tax expense | ||
| NET LOSS | ||
| Net loss attributable to ordinary shareholders | ||
| Other comprehensive income (loss) | ||
| Foreign currency translation income (loss) | ||
| TOTAL COMPREHENSIVE LOSS | ||
| Basic loss per share | ||
| Diluted loss per share | ||
| Weighted average number of ordinary shares outstanding - basic | ||
| Weighted average number of ordinary shares outstanding - diluted |
Loading...
